These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation. Tewa-Tagne P; Briançon S; Fessi H Eur J Pharm Sci; 2007 Feb; 30(2):124-35. PubMed ID: 17150339 [TBL] [Abstract][Full Text] [Related]
3. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs. Tewa-Tagne P; Degobert G; Briançon S; Bordes C; Gauvrit JY; Lanteri P; Fessi H Pharm Res; 2007 Apr; 24(4):650-61. PubMed ID: 17318421 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Abdelwahed W; Degobert G; Fessi H Int J Pharm; 2006 Feb; 309(1-2):178-88. PubMed ID: 16326053 [TBL] [Abstract][Full Text] [Related]
5. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying. Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478 [TBL] [Abstract][Full Text] [Related]
6. The effect of operating and formulation variables on the morphology of spray-dried protein particles. Maa YF; Costantino HR; Nguyen PA; Hsu CC Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449 [TBL] [Abstract][Full Text] [Related]
7. Spray-dried diclofenac-loaded poly(epsilon-caprolactone) nanocapsules and nanospheres. Preparation and physicochemical characterization. Müller CR; Schaffazick SR; Pohlmann AR; de Lucca Freitas L; Pesce da Silveira N; Dalla Costa T; Guterres SS Pharmazie; 2001 Nov; 56(11):864-7. PubMed ID: 11817171 [TBL] [Abstract][Full Text] [Related]
8. Design of porous microparticles with single-micron size by novel spray freeze-drying technique using four-fluid nozzle. Niwa T; Shimabara H; Kondo M; Danjo K Int J Pharm; 2009 Dec; 382(1-2):88-97. PubMed ID: 19686828 [TBL] [Abstract][Full Text] [Related]
9. The influence of formulation components on the aerosolisation properties of spray-dried powders. Rabbani NR; Seville PC J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334 [TBL] [Abstract][Full Text] [Related]
10. Spray-dried powders improve the controlled release of antifungal tioconazole-loaded polymeric nanocapsules compared to with lyophilized products. Ribeiro RF; Motta MH; Härter APG; Flores FC; Beck RCR; Schaffazick SR; de Bona da Silva C Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():875-884. PubMed ID: 26652443 [TBL] [Abstract][Full Text] [Related]
11. Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration. Demana PH; Davies NM; Hook S; Rades T J Control Release; 2005 Mar; 103(1):45-59. PubMed ID: 15710499 [TBL] [Abstract][Full Text] [Related]
12. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation. van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699 [TBL] [Abstract][Full Text] [Related]
13. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids. Hadinoto K; Phanapavudhikul P; Kewu Z; Tan RB Int J Pharm; 2007 Mar; 333(1-2):187-98. PubMed ID: 17084567 [TBL] [Abstract][Full Text] [Related]
14. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs. Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803 [TBL] [Abstract][Full Text] [Related]
15. Improved tretinoin photostability in a topical nanomedicine replacing original liquid suspension with spray-dried powder with no loss of effectiveness. Marchiori MC; Rascovetzki RH; Ourique AF; Rigo LA; Silva CB; Beck RC Drug Dev Ind Pharm; 2013 Apr; 39(4):579-86. PubMed ID: 22697376 [TBL] [Abstract][Full Text] [Related]
16. Aerosolization properties, surface composition and physical state of spray-dried protein powders. Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594 [TBL] [Abstract][Full Text] [Related]
17. Influence of benzyl benzoate as oil core on the physicochemical properties of spray-dried powders from polymeric nanocapsules containing indomethacin. Guterres SS; Weiss V; de Lucca Freitas L; Pohlmann AR Drug Deliv; 2000; 7(4):195-9. PubMed ID: 11195425 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery. Pilcer G; Vanderbist F; Amighi K Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609 [TBL] [Abstract][Full Text] [Related]
19. Redispersible drug nanoparticles prepared without dispersant by electro-spray drying. Ho H; Lee J Drug Dev Ind Pharm; 2012 Jun; 38(6):744-51. PubMed ID: 22010908 [TBL] [Abstract][Full Text] [Related]